Azithromycin effectiveness against intracellular infections of Francisella

被引:42
作者
Ahmad, Saira [1 ]
Hunter, Lyman [2 ]
Qin, Aiping [3 ,4 ]
Mann, Barbara J. [3 ,4 ]
van Hoek, Monique L. [1 ]
机构
[1] George Mason Univ, Natl Ctr Biodef & Infect Dis, Dept Mol & Microbiol, Manassas, VA USA
[2] Inova Fairfax Hosp, Falls Church, VA 22042 USA
[3] Univ Virginia Hlth Syst, Dept Med, Charlottesville, VA 22908 USA
[4] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA
来源
BMC MICROBIOLOGY | 2010年 / 10卷
关键词
RESISTANCE EFFLUX PUMPS; LIVE VACCINE STRAIN; IN-VITRO; MULTIDRUG-RESISTANCE; ESCHERICHIA-COLI; INTRAMACROPHAGE GROWTH; MACROLIDE RESISTANCE; GALLERIA-MELLONELLA; MURINE MACROPHAGES; EPITHELIAL-CELLS;
D O I
10.1186/1471-2180-10-123
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Macrolide antibiotics are commonly administered for bacterial respiratory illnesses. Azithromycin (Az) is especially noted for extremely high intracellular concentrations achieved within macrophages which is far greater than the serum concentration. Clinical strains of Type B Francisella (F.) tularensis have been reported to be resistant to Az, however our laboratory Francisella strains were found to be sensitive. We hypothesized that different strains/species of Francisella (including Type A) may have different susceptibilities to Az, a widely used and well-tolerated antibiotic. Results: In vitro susceptibility testing of Az confirmed that F. tularensis subsp. holarctica Live Vaccine Strain (LVS) (Type B) was not sensitive while F. philomiragia, F. novicida, and Type A F. tularensis (NIH B38 and Schu S4 strain) were susceptible. In J774A. 1 mouse macrophage cells infected with F. philomiragia, F. novicida, and F. tularensis LVS, 5 mu g/ml Az applied extracellularly eliminated intracellular Francisella infections. A concentration of 25 mu g/ml Az was required for Francisella-infected A549 human lung epithelial cells, suggesting that macrophages are more effective at concentrating Az than epithelial cells. Mutants of RND efflux components (tolC and ftlC) in F. novicida demonstrated less sensitivity to Az by MIC than the parental strain, but the tolC disc-inhibition assay demonstrated increased sensitivity, indicating a complex role for the outer-membrane transporter. Mutants of acrA and acrB mutants were less sensitive to Az than the parental strain, suggesting that AcrAB is not critical for the efflux of Az in F. novicida. In contrast, F. tularensis Schu S4 mutants Delta acrB and Delta acrA were more sensitive than the parental strain, indicating that the AcrAB may be important for Az efflux in F. tularensis Schu S4. F. novicida LPS O-antigen mutants (wbtN, wbtE, wbtQ and wbtA) were found to be less sensitive in vitro to Az compared to the wild-type. Az treatment prolonged the survival of Galleria (G.) mellonella infected with Francisella. Conclusion: These studies demonstrate that Type A Francisella strains, as well as F. novicida and F. philomiragia, are sensitive to Az in vitro. Francisella LPS and the RND efflux pump may play a role in Az sensitivity. Az also has antimicrobial activity against intracellular Francisella, suggesting that the intracellular concentration of Az is high enough to be effective against multiple strains/species of Francisella, especially in macrophages. Az treatment prolonged survival an in vivo model of Francisella-infection.
引用
收藏
页数:15
相关论文
共 59 条
  • [11] Comparative Genomic Characterization of Francisella tularensis Strains Belonging to Low and High Virulence Subspecies
    Champion, Mia D.
    Zeng, Qiandong
    Nix, Eli B.
    Nano, Francis E.
    Keim, Paul
    Kodira, Chinnappa D.
    Borowsky, Mark
    Young, Sarah
    Koehrsen, Michael
    Engels, Reinhard
    Pearson, Matthew
    Howarth, Clint
    Larson, Lisa
    White, Jared
    Alvarado, Lucia
    Forsman, Mats
    Bearden, Scott W.
    Sjoestedt, Anders
    Titball, Richard
    Michell, Stephen L.
    Birren, Bruce
    Galagan, James
    [J]. PLOS PATHOGENS, 2009, 5 (05)
  • [12] The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli
    Chollet, R
    Chevalier, J
    Bryskier, A
    Pagés, JM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) : 3621 - 3624
  • [13] Cowley SC, 2000, FEMS MICROBIOL LETT, V182, P63, DOI 10.1016/S0378-1097(99)00570-4
  • [14] Francisella tularensis invasion of lung epithelial cells
    Craven, Robin R.
    Hall, Joshua D.
    Fuller, James R.
    Taft-Benz, Sharon
    Kawula, Thomas H.
    [J]. INFECTION AND IMMUNITY, 2008, 76 (07) : 2833 - 2842
  • [15] Dichiara A J, 2008, Minerva Gastroenterol Dietol, V54, P307
  • [16] Efficacy, safety and tolerability of 3 day azithromycin versus 10 day co-amoxiclav in the treatment of children with acute lower respiratory tract infections
    Ferwerda, A
    Moll, HA
    Hop, WCJ
    Kouwenberg, JM
    Gi, CVTP
    Robben, SGF
    de Groot, R
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (04) : 441 - 446
  • [17] Lung transplantation: The role of azithromycin in the management of patients with bronchiolitis obliterans syndrome
    Fietta, A. M.
    Meloni, F.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2008, 15 (07) : 716 - 723
  • [18] IDENTIFICATION OF FRANCISELLA SPECIES AND DISCRIMINATION OF TYPE-A AND TYPE-B STRAINS OF FRANCISELLA-TULARENSIS BY 16S RIBOSOMAL-RNA ANALYSIS
    FORSMAN, M
    SANDSTROM, G
    JAURIN, B
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1990, 56 (04) : 949 - 955
  • [19] A comprehensive transposon mutant library of Francisella novicida, a bioweapon surrogate
    Gallagher, Larry A.
    Ramage, Elizabeth
    Jacobst, Michael A.
    Kaul, Rajinder
    Brittnacher, Mitchell
    Manoil, Colin
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (03) : 1009 - 1014
  • [20] Deletion of TolC orthologs in Francisella tularensis identifies roles in multidrug resistance and virulence
    Gil, Horacio
    Platz, Gabrielle J.
    Forestal, Colin A.
    Monfett, Michael
    Bakshi, Chandra Shekhar
    Seliati, Timothy J.
    Furie, Martha B.
    Benach, Jorge L.
    Thanassi, David G.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (34) : 12897 - 12902